Biocytogen

Biocytogen

生物技术研究

Waltham,Massachusetts 9,371 位关注者

Your Partner From Targets To Therapeutics

关于我们

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab? mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.

网站
https://www.biocytogen.com/
所属行业
生物技术研究
规模
1,001-5,000 人
总部
Waltham,Massachusetts
类型
上市公司
创立
2009
领域
Preclinical Services、Animal Models、Gene Targeting、Humanized Immune-oncology Checkpoint Mouse、Immune-deficient mouse model、Antibody Research and Development、Animal Production and Breeding、In vivo study、Fully human antibody mouse、Immuno-Oncology、Antibody discovery、Preclinical CRO、Pharmacology和Antibody Licensing

地点

  • 主要

    300 3rd Ave, FL6

    US,Massachusetts,Waltham,02451

    获取路线
  • No. 12 Baoshen South Street

    Daxing Bio-Medicine Industry Park, Daxing District

    CN,Beijing,102609

    获取路线
  • B12 building, Biotech and Pharmaceutical Park, Linjiang New District

    CN,Jiangsu

    获取路线
  • Waldhofer Str.102

    DE,Heidelberg,Heidelberg,69123

    获取路线
  • 611 Gateway Blvd

    US,California,South San Francisco,94080

    获取路线

Biocytogen员工

动态

相似主页

查看职位

融资

Biocytogen 共 7 轮

上一轮

上市后股权

US$49,800,000.00

Crunchbase 上查看更多信息